The study aims to evaluate the effects of elexacaftor/tezacaftor/ivacaftor on cough and physical activity using wearable technology.
To find out if this trial is suitable for you please register below or contact our Clinical Trials Team at firstname.lastname@example.org or phone 6151 0888.
Eligibility & Requirements
- Aged 18 or over with a diagnosis of cystic fibrosis and the F508del/MF mutation
- Forced expiratory volume in 1 second (FEV1) value ≥30% and ≤90% predicted
- Heterozygous for CF transmembrane conductance regulator gene (CFTR) F508del mutation and a minimal function mutation (F/MF genotypes)
Dr Siobhain Mulrennan
This Clinical Trial is currently Closed
Please register your interest for future clinical trials and we will contact you when a suitable trial becomes available.
Current Clinical Trials